SCHEMBL28708312

SCHEMBL28708312

CN(C(=O)Oc1nc(CC(N)=O)cs1)C(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ALDH1A1 P00352 6/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ GABRA5 P31644 1/20 0.34
▸ GABRB2 P47870 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ CSNK2A1 P68400 1/20 0.32
▸ HPGD P15428 3/20 0.32
▸ KDM4E B2RXH2 3/20 0.32
▸ GAA P10253 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ TP53 P04637 1/20 0.31
▸ MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28302432 0.71 MEN1 (0.45) MEN1KMT2AALDH1A1HSD17B10GABRA5
SCHEMBL5592616 0.69 MEN1 (0.40) MEN1KMT2AALDH1A1HSD17B10GABRA5
SCHEMBL28031249 0.69 MEN1 (0.63) MEN1KMT2AALDH1A1HSD17B10GABRA5
SCHEMBL28316724 0.68 GABRA5 (0.32) MEN1KMT2AALDH1A1HSD17B10GABRA5
SCHEMBL15581617 0.68 MEN1 (0.41) MEN1KMT2AALDH1A1HSD17B10GABRA5
SCHEMBL5544014 0.67 SMN1; SMN2 (0.57) ALDH1A1HSD17B10GABRA5GABRB2RAB9A
SCHEMBL5600338 0.67 MEN1 (0.37) MEN1KMT2AALDH1A1HSD17B10GABRA5
SCHEMBL13412480 0.65 ALDH1A1 (0.40) MEN1KMT2AALDH1A1HSD17B10GABRA5
SCHEMBL1797901 0.65 GABRA5 (0.72) MEN1KMT2AALDH1A1HSD17B10GABRA5
SCHEMBL2895259 0.65 GABRA5 (0.47) MEN1KMT2AALDH1A1HSD17B10GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109790164-B Purine and 3-deazapurine analogues as choline kinase inhibitors 内尔维亚诺医疗科学公司 2022-01-25 — — CN disclosed
Send feedback